| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |